Using Gen AI and ML to Improve Clinical Trials for Pharma Companies
2024年2月13日 - 1:20AM
AllPennyStocks.com
With a focus on developing Generative AI and Machine Learning
solutions targeted at the pharmaceutical industry, this company is
launching a new offering to improve clinical trials.
NetraMark...
To read the full story on AllPennyStocks.com, click
here.
NetraMark (CSE:AIAI)
過去 株価チャート
から 4 2024 まで 5 2024
NetraMark (CSE:AIAI)
過去 株価チャート
から 5 2023 まで 5 2024
